Literature DB >> 10499587

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.

R S Ames1, H M Sarau, J K Chambers, R N Willette, N V Aiyar, A M Romanic, C S Louden, J J Foley, C F Sauermelch, R W Coatney, Z Ao, J Disa, S D Holmes, J M Stadel, J D Martin, W S Liu, G I Glover, S Wilson, D E McNulty, C E Ellis, N A Elshourbagy, U Shabon, J J Trill, D W Hay, E H Ohlstein, D J Bergsma, S A Douglas.   

Abstract

Urotensin-II (U-II) is a vasoactive 'somatostatin-like' cyclic peptide which was originally isolated from fish spinal cords, and which has recently been cloned from man. Here we describe the identification of an orphan human G-protein-coupled receptor homologous to rat GPR14 and expressed predominantly in cardiovascular tissue, which functions as a U-II receptor. Goby and human U-II bind to recombinant human GPR14 with high affinity, and the binding is functionally coupled to calcium mobilization. Human U-II is found within both vascular and cardiac tissue (including coronary atheroma) and effectively constricts isolated arteries from non-human primates. The potency of vasoconstriction of U-II is an order of magnitude greater than that of endothelin-1, making human U-II the most potent mammalian vasoconstrictor identified so far. In vivo, human U-II markedly increases total peripheral resistance in anaesthetized non-human primates, a response associated with profound cardiac contractile dysfunction. Furthermore, as U-II immunoreactivity is also found within central nervous system and endocrine tissues, it may have additional activities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10499587     DOI: 10.1038/45809

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  155 in total

1.  Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey.

Authors:  S A Douglas; A C Sulpizio; V Piercy; H M Sarau; R S Ames; N V Aiyar; E H Ohlstein; R N Willette
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Cardiovascular actions of human urotensin II--considerations for hypertension.

Authors:  Fraser D Russell; Peter Molenaar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-19       Impact factor: 3.000

3.  Involvement of a cytoplasmic-tail serine cluster in urotensin II receptor internalization.

Authors:  Christophe D Proulx; May Simaan; Emanuel Escher; Stéphane A Laporte; Gaétan Guillemette; Richard Leduc
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

4.  Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis.

Authors:  Arnold S Kristof; Zhipeng You; Yin-Shan Han; Adel Giaid
Journal:  Peptides       Date:  2010-04-28       Impact factor: 3.750

5.  Urotensin II alters vascular reactivity in animals subjected to volume overload.

Authors:  Gregory S Harris; Robert M Lust; Laxmansa C Katwa; Christopher J Wingard
Journal:  Peptides       Date:  2010-08-17       Impact factor: 3.750

6.  Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.

Authors:  Ying-Ying Li; Zheng-Ming Shi; Xiao-Yong Yu; Ping Feng; Xue-Jiang Wang
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

7.  Dynamic expression pattern of corticotropin-releasing hormone, urotensin I and II genes under acute salinity and temperature challenge during early development of zebrafish.

Authors:  Lei Luo; Aqin Chen; Chongchong Hu; Weiqun Lu
Journal:  Fish Physiol Biochem       Date:  2014-08-26       Impact factor: 2.794

8.  Urotensin upregulates transforming growth factor-β1 expression of asthma airway through ERK-dependent pathway.

Authors:  Wei-Xi Zhang; Ya-Feng Liang; Xiao-Ming Wang; Ying Nie; Lei Chong; Li Lin; Chun Chen; Chang-Chong Li
Journal:  Mol Cell Biochem       Date:  2012-01-21       Impact factor: 3.396

9.  A new ligand for the urotensin II receptor.

Authors:  Valeria Camarda; Remo Guerrini; Evi Kostenis; Anna Rizzi; Girolamo Calò; Almut Hattenberger; Marina Zucchini; Severo Salvadori; Domenico Regoli
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

10.  Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects.

Authors:  Z Wenyi; S Suzuki; M Hirai; Y Hinokio; Y Tanizawa; A Matsutani; J Satoh; Y Oka
Journal:  Diabetologia       Date:  2003-06-27       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.